Innovative Analyses Support a Role for DNA Damage and an Aberrant Cell Cycle in Myelodysplastic Syndrome Pathogenesis
David R. Head(University of Southern California), Keith Shults(Center for Innovation), Andrew A. Shinar(Vanderbilt University Medical Center), James W. Jacobberger(University Hospitals Cleveland Medical Center), Stacey Goodman(Texas Oncology), Sara A. McClintock-Treep(Vanderbilt University), Claudio A. Mosse(Breast Cancer Research Foundation), Madan Jagasia(Vanderbilt University Medical Center), William D. Dupont(Vanderbilt University Medical Center), Robert C. Briggs(Vanderbilt University), Leanne A. Flye(Center for Innovation), Greg Stelzer(Center for Innovation)
Cited by 10
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
|New England Journal of Medicine|1985|1.9k
Age and acute myeloid leukemia
|Blood|2006|1.4k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k